Merck snags Chinese obesity drug in nearly $2 billion deal ...Middle East

Fortune - News
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More

Hence then, the article about merck snags chinese obesity drug in nearly 2 billion deal was published today ( ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Merck snags Chinese obesity drug in nearly $2 billion deal )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News